Opinion: Share Diverse Genomic Data

Personalized interpretation is the next frontier in clinical genomics, but we won’t get there without sharing data representing all ethnic groups.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ISTOCK, JEZPERKLAUZENIn just 15 years, we have gone from the first rough draft of the human genome to early successes in using genomic information to improve patient care. The rate of progress has been astonishing. But we still have a long way to go before we realize the full potential of routine genome sequencing in the clinic. Perhaps the single most important element we need right now is better context for genome interpretation—access to the relevant data that help medical geneticists and other healthcare professionals pinpoint disease-causing DNA variants, and translate DNA variants into actionable insights that help ensure each patient receives the best course of treatment.

That’s why a collection of academic and commercial organizations, my company among them, banded together to form the Allele Frequency Community, a group we believe will help deliver critical context needed for sequence interpretation to the biomedical community—all built upon effective, responsible data sharing. This community-driven effort is designed to make clinically useful genomic information broadly available to researchers and clinicians alike.

Current genomic databases are extremely valuable for research, but often lack a diverse representation of ethnic groups from around the globe. Clinical geneticists trying to determine whether a particular variant is relevant for a patient from one of these underrepresented ethnic groups face a serious challenge, as simple approaches can yield a number of “red herring” variants thought to be disease-causing that are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Ramon Felciano

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours